Trevor Moody
Managing Director @ M. H. Carnegie & Co.
Seattle, United States
Trevor Moody is a private equity investor at M. H. Carnegie & Co. in Seattle focused on Medical and Health Care. Trevor brings significant experience with over 25 years in the development, commercialization and funding of innovative, growth-oriented medical technologies. He was most recently a General Partner at Frazier Healthcare Ventures, a leading healthcare venture capital and private equity investment firm with over $2.0 billion under management. Trevorco-led the medical device team for almost a decade at Frazier and became known as an active and well-regarded investor. Prior to Frazier Healthcare, he was a Senior Consultant at The Wilkerson Group. Trevor graduated from MIT with an MS in Management (Sloan School) and the University of Southern Queensland, Australia with a Bachelor of Electrical Engineering. Trained as a Biomedical Engineer, he held product development and marketing roles at Telectronics Pacing Systems and Ventritex, both in the cardiology market. Trevor is immediate past board chair of the Center for Infectious Disease Research, one of the largest independent, non-profit research institutes focused on diseases of the developing world. He is also a board member of electroCore, Serene Medical, and Simplify Medical.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Trevor Moody invests in
Stages Trevor Moody invests in
Countries Trevor Moody invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
EBR Systems
|
EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management. EBR Systems develops devices for the treatment of cardiac arrhythmias. | $30M / Private Equity / Aug 27, 2019 | |
|
EBR Systems
|
EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management. EBR Systems develops devices for the treatment of cardiac arrhythmias. | $50M / Private Equity / Nov 14, 2017 |
Co-Investors
About M. H. Carnegie & Co.
M.H. Carnegie & Co. was launched by Mark Carnegie in 2010 with total equity commitments of $132 million to capitalise on the post financial crisis environment in the Australian market for smaller alternative investment opportunities. M.H. Carnegie & Co. was launched with a focus and expertise in expansion capital, as well as operating realestate.
M. H. Carnegie & Co. Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Mark Carnegie
Founder
|
|||
|
Trevor Moody
Managing Director
|
|||
Kate Thompson
Partner
|
|||
Matthew Beach
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Trevor Moody invest in?
Trevor Moody invests primarily in Medical, Health Care and Biotechnology startups, most often at Private Equity stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Trevor Moody?
Public channels for Trevor Moody include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Trevor Moody last invest?
The most recent investment recorded for Trevor Moody closed in Aug 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
